Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FS Grifols versus Evicel for adjunctive surgical hemostasis in pediatric patients
2016-004489-24Phase 3Completed
- Sponsor
- Instituto Grifols
- Start
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Factor VIII and porcine fibrin sealant in intraoperative bleeding (2 arms), sponsored by Instituto Grifols. Primary endpoint: Primary efficacy endpoint. Started Apr 2018; status: completed.
02
Drugs
Factor VIIIporcine fibrin sealant
03
Conditions
intraoperative bleeding
Beyond the preview
Go deeper on 2016-004489-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004489-24.